Drugs / Cytokine-induced killer cell immunotherapy
Cytokine-induced killer cell immunotherapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02280278 | Oct 2014 → Oct 2019 | malignant colon neoplasm | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cytokine-induced killer cell immunotherapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02280278 ↗ |
| Modality | Cell therapy | “CIK cell therapy can improve the survival rate of stage III colon cancer patients” NCT02280278 ↗ |